Summary
The pharmacokinetics of two slow release theophylline preparations “Theo-Dur” (T) containing theophylline only and “Phyllocontin” (P) containing aminophylline have been compared in 12 patients with asthma. Each patient received both treatments in random order. The dose of treatment administered 12 hourly was increased or decreased to produce plasma theophylline concentrations of 10–20 mg/l at clinic visits normally 7 to 8 h after dosing. Pharmacokinetic studies were carried out after at least one week's treatment with this dose. After the first study day patients were crossed over to the second treatment at a dosage providing a similar amount of theophylline. They returned for a second study day after at least one week. Comparison of the dose corrected AUC, time to peak concentrations, within patient coefficients of variation (CV), number of concentration time points falling within 25% of Cmax and percentage fluctuations in plasma concentration showed no significant differences between the two preparations.
Similar content being viewed by others
References
Chang J, Gotcher S, Gushaw JB (1982) Homogeneous enzyme immunoassay for theophylline in serum and plasma. Clin Chem 28: 361–367
Fagerstrom PO, Heintz L (1983) Absorption of sustained release theophylline tablets. Int J Clin Pharmacol Ther Tox 21: 359–362
Gal P, Jusko WJ, Yurchak AM, Franklin BA (1978) Theophylline disposition in obesity. Clin Pharmacol Ther 23: 438–444
Jackson SHD, Peverel Cooper CA, Turner TH (1985) Personality and theophylline pharmacokinetics. Eur J Clin Pharmacol 28: 429–431
Jackson SHD, Wright JM (1983) Sustained serum theophylline concentrations during chronic twice daily administration of a slow release preparation. Eur J Clin Pharmacol 24: 205–208
Melethil S, Carlson JD, Haug MT (1982) Predictability of theophylline levels. Drug Intell Clin Pharm 16: 695–697
Weinberger M, Hendeles L (1983) Current concepts. Slow-release theophylline. Rationale and basis for product selection. N Engl J Med 308: 760–764
Author information
Authors and Affiliations
Additional information
Merck Company Foundation Research Fellow in Clinical Pharmacology Division of Clinical Pharmacology, University of Texas Health Science Center at San Antonio, Texas, USA
Rights and permissions
About this article
Cite this article
Jackson, S.H.D., Shah, K. & Turner, P. Methods of comparing pharmacokinetics of slow release preparations: a comparison of “Theo-Dur” and “Phyllocontin” in patients with asthma. Eur J Clin Pharmacol 30, 313–317 (1986). https://doi.org/10.1007/BF00541535
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00541535